Distribution parallels distribution of all biotechnology companies with main state being Victoria, then New South Wales. Western Australia has disproportionately more than Queensland which suggests that they may be more fragile.
2.
Major sector is Human Health followed by Equipment and Services then daylight
3.
Two periods of strong creation of companies: mid 80s and turn of the century.
4.
63% of companies valued less than $20 million and 80% less than $40 million.
5.
70% of companies turn over less than $5 million and 53% turn over less than $2 million.